MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive (loss) income
-$171,393K
Net (loss) income
-$171,298K
Unrealized (losses) gains
on...
-$95K
Income tax (benefit)
expense
-$80K
Interest income
$10,669K
(loss) income before
income tax (benefit)...
-$171,378K
Total other income,
net
$8,070K
Product
$72,192K
Revenue Under
Collaboration Agreements
$9,716K
Revenue Under Supply
Agreements
$2,370K
Interest expense
(including related party...
$2,599K
Loss from operations
-$179,448K
Total revenue
$84,278K
Total operating
expenses
$263,726K
Selling, general and
administrative (including...
$230,122K
Cost of goods sold
(including related party...
$20,423K
Research and development
(including related party...
$13,181K
Back
Back
Income Statement
source: myfinsight.com
ARS Pharmaceuticals, Inc. (SPRY)
ARS Pharmaceuticals, Inc. (SPRY)